Inhibrx Biosciences, Inc. INBX Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s interest coverage?
- Inhibrx Biosciences, Inc. (INBX) reported interest coverage of -9.5× in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s interest coverage changed year-over-year?
- Inhibrx Biosciences, Inc.'s interest coverage increased by 74.7% year-over-year, from -37.3× to -9.5×.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s interest coverage?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s interest coverage has grown at a 26.8% compound annual growth rate (CAGR), from -6.9× to -11.1×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.